BTG Pactual Asset Management US’s Elevance Health ELV Stock Holding History

BTG Pactual Asset Management US’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$350K	Buy	+906	New	+$336K	0.02%	321

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BTG Pactual Asset Management US's ELV Position: Q2 2026 in Review

BTG Pactual Asset Management US opened a new position in Elevance Health (ELV) in Q2 2026: 906 shares worth $350K. The stake represents 0.02% of the portfolio and ranks #321 among its holdings.

1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

BTG Pactual Asset Management US held 906 shares of Elevance Health worth $350K as of Q2 2026.
Elevance Health was a new BTG Pactual Asset Management US position in Q2 2026.
Elevance Health made up 0.02% of BTG Pactual Asset Management US's portfolio in Q2 2026, its #321 holding.
1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on BTG Pactual Asset Management US's 13F filing for Q2 2026, filed 14 Aug 2026.